Skip to main
CLRB
CLRB logo

Cellectar BioSciences (CLRB)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Cellectar BioSciences (CLRB) Stock

About Cellectar BioSciences (CLRB)

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting ne...read more
Market cap$16.11M
Yesterday's volume14.13K
Revenue (TTM)
Avg. daily volume160.07K
EBITDA (TTM)-$29.8M
Open$3.70
Price / earnings ratio-0.36x
Yesterday's range$3.61 - $3.83
Debt / equity4.61x
52 week range$2.71 - $42.3
5 year debt / equity1.18x
Beta (LTM)0.43x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.77x
Ex-dividend date
Next earningsMar 12, 2026
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for CLRB stock is $16.12M

The current P/E ratio for CLRB stock is -0.36

The 52-week high for CLRB stock is $42.30. The current CLRB stock price $undefined is 100.00% below its 52-week high

The 52-week low for CLRB stock is $2.71. The current CLRB stock price $undefined has increased 100.00% from its 52-week low

No, the CLRB stock does not pay dividends to its shareholders

How to buy CLRB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CLRB stock

    Navigate to the Explore page. Then, type CLRB into the search bar. When you see CLRB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CLRB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cellectar BioSciences Stock Earnings

The value each CLRB share was expected to gain vs. the value that each CLRB share actually gained.

Cellectar BioSciences (CLRB) reported Q3 2025 earnings per share (EPS) of -$1.41, beating estimates of -$2.28 by 38.16%. In the same quarter last year, Cellectar BioSciences's earnings per share (EPS) was -$12. Cellectar BioSciences is expected to release next earnings on 03/12/2026, with an earnings per share (EPS) estimate of -$1.21.

Buy Cellectar BioSciences (CLRB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.